Peripheral antinociceptive effect of 2‐arachidonoyl‐glycerol and its interaction with endomorphin‐1 in arthritic rat ankle joints

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2010-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1440-1681.2010.05346.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• ANTINOCICEPTIVE INTERACTIONS BETWEEN ANANDAMIDE AND ENDOMORPHIN‐1 AT THE SPINAL LEVEL

  2009cited by this paper
• The Peripheral Antinociceptive Effects of Endomorphin-1 and Kynurenic Acid in the Rat Inflamed Joint Model

  2009cited by this paper
• Spinal Microglial and Perivascular Cell Cannabinoid Receptor Type 2 Activation Reduces Behavioral Hypersensitivity without Tolerance after Peripheral Nerve Injury

  2008cited by this paper
• Analgesic synergy between topical opioids and topical non-steroidal anti-inflammatory drugs in the mouse model of thermal pain.

  2008cited by this paper
• Endogenous Cannabinoids: Structure and Metabolism

  2008cited by this paper
• Modulation of the anti‐nociceptive effects of 2‐arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model

  2008cited by this paper
• Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees.

  2008cited by this paper
• Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

  2008cited by this paper
• Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation*

  2008cited by this paper
• Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis.

  2008influential reference
• Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis

  2008cited by this paper
• Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

  2007cited by this paper
• Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.

  2007cited by this paper
• Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

  2007cited by this paper
• Biochemistry and pharmacology of endovanilloids.

  2007cited by this paper
• The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2 receptors

  2007cited by this paper
• Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti‐inflammatory drug, in acute and inflammatory pain

  2006cited by this paper
• Interaction of endogenous ligands mediating antinociception.

  2006cited by this paper
• Peripheral Antinociceptive Effects of Exogenous and Immune Cell-Derived Endomorphins in Prolonged Inflammatory Pain

  2006cited by this paper
• Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception.

  2005cited by this paper
• Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats.

  2004cited by this paper
• Synergistic interactions between cannabinoid and opioid analgesics.

  2004cited by this paper
• Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice.

  2004cited by this paper
• Loss of vasomotor responsiveness to the mu-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints.

  2004cited by this paper
• Cannabinoids and pain

  2003cited by this paper
• A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.

  2003cited by this paper
• Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration

  2003cited by this paper
• Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

  2003cited by this paper
• Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses.

  2003cited by this paper
• Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats

  2003cited by this paper
• Topical cannabinoid enhances topical morphine antinociception

  2003cited by this paper
• Opioid Peptides Endomorphin‐1 and Endomorphin‐2 in the Immune System in Humans and in a Rodent Model of Inflammation

  2002cited by this paper
• Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives.

  2002cited by this paper
• Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints

  2001cited by this paper
• Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons.

  2000cited by this paper
• Opioids and Their Complicated Receptor Complexes

  2000cited by this paper
• Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2*

  2000cited by this paper
• Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists.

  2000cited by this paper
• Synergistic interactions of endogenous opioids and cannabinoid systems.

  1999cited by this paper
• Pharmacological and biochemical interactions between opioids and cannabinoids.

  1999cited by this paper
• An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.

  1998cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

  1998cited by this paper
• 2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+‐dependent and ‐independent mechanisms

  1998cited by this paper
• A potent and selective endogenous agonist for the mu-opiate receptor.

  1997cited by this paper
• Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals.

  1997cited by this paper
• AIDS, Drugs of Abuse, and the Neuroimmune Axis

  1996cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• Peripheral Mechanisms of Opioid Analgesia

  1993cited by this paper
• Local analgesic effect of endogenous opioid peptides.

  1993cited by this paper
• Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.

  1992cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Analysis of serial measurements in medical research.

  1990cited by this paper
• Statistical analysis of drug-drug and site-site interactions with isobolograms.

  1989cited by this paper
• Multiple opiate receptor sites on primary afferent fibres

  1980cited by this paper

• Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  2022cites this paper
• Endocannabinoid and Prostanoid Crosstalk in Pain.

  2019cites this paper
• Epidermal Endocannabinoid System (EES) and its Cosmetic Application

  2019cites this paper
• Pharmacological Aspects of Anandamide and 2-Arachidonoyglycerol as Bioactive Lipids

  2017cites this paper
• Mechanisms and Mediators That Drive Arthritis Pain

  2015cites this paper
• Use of resistance exercise as a factor antagonized by naloxone of analgesia in acute knee synovitis in Wistar rats

  2012cites this paper
• Cannabinoids and muscular pain. Effectiveness of the local administration in rat

  2012cites this paper
• The Effects of Peptide and Lipid Endocannabinoids on Arthritic Pain at the Spinal Level

  2012cites this paper
• Cannabinoids and muscular pain. Effectiveness of the local administration in rat

  2012cites this paper
• The MAGL Inhibitor, JZL184, Attenuates LiCl-Induced Vomiting in the Suncus murinus and 2AG Attenuates LiCl-Induced Nausea-Like Behavior in Rats

  2011cites this paper
• Endogenous opiates and behavior: 2010.

  2011cites this paper
• Topical application of analgesics: a clinical option in day case anaesthesia?

  2010cites this paper